Related Experiment Video
Updated: Jun 19, 2026

10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
The structural basis of pregnane X receptor binding promiscuity.
Chi-Ho Ngan1, Dmitri Beglov, Aleksandra N Rudnitskaya
1Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, USA.
Biochemistry
|October 28, 2009
Summary
The human pregnane X receptor (PXR) binds many compounds due to its adaptable binding site. Computational analysis revealed five key
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- The human pregnane X receptor (PXR) is a nuclear receptor that regulates genes involved in the metabolism of steroids and xenobiotics.
- PXR is known for its ability to bind a wide array of structurally diverse compounds, making it a promiscuous protein.
- Unlike many other promiscuous proteins, PXR's structure remains largely unchanged upon ligand binding.
Purpose of the Study:
- To investigate the structural basis for the broad ligand-binding promiscuity of the human pregnane X receptor (PXR).
- To identify and characterize the "hot spots" within the PXR binding site that contribute significantly to ligand binding free energy.
Main Methods:
- Computational solvent mapping was employed to identify and characterize hot spots in the PXR binding site.
- Analysis of conserved residues and side chain flexibility within the identified hot spots.
Main Results:
- PXR possesses a smooth, nearly spherical binding site with a well-defined hot spot structure comprising five key regions.
- Three hot spots are present even in the ligand-free PXR, with the most significant one formed by conserved residues W299, F288, and Y306.
- Ligand binding is accommodated by extending into multiple hot spots, explaining PXR's ability to bind diverse compounds.
- Hot spot locations are conserved across mammalian PXRs, and movable side chains further enhance ligand size accommodation.
Conclusions:
- The structural features of the PXR binding site, including multiple conserved and flexible hot spots, explain its remarkable ligand promiscuity.
- These findings suggest conserved evolutionary mechanisms for PXR ligand recognition and potential implications for drug development.
- A unique signal transduction pathway between the PXR homodimerization interface and coactivator binding site was also suggested.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
